ULTRASENSITIVE PROSTATE-SPECIFIC ANTIGEN NADIR AND TIME TO NADIR AS INDEPENDENT PREDICTORS OF BIOCHEMICAL RECURRENCE IN PATIENTS AFTER RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER

被引：1
|
作者：
Vesely, S. [1 ,2 ]
Jarolim, L. [1 ,2 ]
Babjuk, M. [1 ,2 ]
Dusek, P. [1 ,2 ]
Kaliska, V. [1 ,2 ]
Schmidt, M. [1 ,2 ]
机构：
[1] Charles Univ Prague, Fac Med 2, Prague, Czech Republic
[2] Charles Univ Prague, Univ Hosp Motol, Dept Urol, Prague, Czech Republic
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2010年 / 9卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(10)60848-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：274 / 274
页数：1
相关论文
共 50 条
  • [1] Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical Recurrence
    Skove, Stephanie L.
    Howard, Lauren E.
    Aronson, William J.
    Terris, Martha K.
    Kane, Christopher J.
    Amling, Christopher L.
    Cooperberg, Matthew R.
    Moreira, Daniel M.
    Freedland, Stephen J.
    UROLOGY, 2017, 108 : 129 - 134
  • [2] ULTRASENSITIVE PROSTATE-SPECIFIC ANTIGEN NADIR AND TIME TO NADIR CAN BE USED TO IDENTIFY MEN WHO ARE AT HIGH RISK OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY
    Vesely, Stepan
    Jarolim, Ladislav
    Babjuk, Marko
    Dusek, Pavel
    Kaliska, Veronika
    Schmidt, Marek
    JOURNAL OF UROLOGY, 2010, 183 (04): : E159 - E159
  • [3] Usefulness of the nadir value of serum prostate-specific antigen measured by an ultrasensitive assay as a predictor of biochemical recurrence after radical prostatectomy for clinically localized prostate cancer
    Sakai, I
    Harada, K
    Kurahashi, T
    Muramaki, M
    Yamanaka, K
    Hara, I
    Inoue, T
    Miyake, H
    UROLOGIA INTERNATIONALIS, 2006, 76 (03) : 227 - 231
  • [4] Prognostic Significance of Undetectable Ultrasensitive Prostate-specific Antigen Nadir After Radical Prostatectomy
    Hong, Sung Kyu
    Park, Hong Zoo
    Lee, Won Ki
    Kim, Dae Sung
    Lee, June Suk
    Doo, Seung Hwan
    Jeong, Seong Jin
    Yoon, Cheol Yong
    Byun, Seok-Soo
    Lee, Sang Eun
    UROLOGY, 2010, 76 (03) : 723 - 727
  • [5] PROGNOSTIC SIGNIFICANCE OF UNDETECTABLE ULTRASENSITIVE PROSTATE-SPECIFIC ANTIGEN NADIR AFTER RADICAL PROSTATECTOMY
    Hong, Sung Kyu
    Park, Hongzoo
    Kim, Dae Sung
    Lee, Won Ki
    Doo, Seung Hwan
    Jeong, Seong Jin
    Yoon, Cheol Yong
    Byun, Seok-Soo
    Lee, Sang Eun
    JOURNAL OF UROLOGY, 2010, 183 (04): : E158 - E158
  • [6] Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value
    Chung, Jae Hoon
    Jeong, Jae Yong
    Lee, Ji Youl
    Song, Was
    Kang, Minyong
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong I. L.
    Lee, Hyun Moo
    Jeon, Seong Soo
    PLOS ONE, 2021, 16 (05):
  • [7] THE ASSOCIATION BETWEEN NADIR PROSTATE SPECIFIC ANTIGEN VALUE AND BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
    Chung, Jae Hoon
    Jeon, Seong Soo
    Jeong, Jae Yong
    Kang, Minyong
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Lee, Hyun Moo
    JOURNAL OF UROLOGY, 2020, 203 : E994 - E995
  • [8] Prognostic Significance of Undetectable Ultrasensitive Prostate-specific Antigen Nadir After Radical Prostatectomy EDITORIAL COMMENT
    Moul, Judd W.
    UROLOGY, 2010, 76 (03) : 727 - 727
  • [9] IMPACT OF TIME TO UNDETECTABLE PROSTATE-SPECIFIC ANTIGEN NADIR AS A PREDICTOR OF BIOCHEMICAL RECURRENCE IN PATIENTS WITH POSITIVE SURGICAL MARGINS FOLLOWING RADICAL PROSTATECTOMY
    Koo, Kyo Chul
    Choi, Ho Chul
    Rha, Koon Ho
    Choi, Young Deuk
    Hong, Sung Joon
    Chung, Byung Ha
    Rha, Koon Ho
    JOURNAL OF UROLOGY, 2014, 191 (04): : E712 - E713
  • [10] The impact of time to prostate specific antigen nadir on biochemical recurrence and mortality rates after radiation therapy for localized prostate cancer
    Wenzel, Mike
    Dariane, Charles
    Saad, Fred
    Karakiewicz, Pierre I.
    Mandel, Philipp
    Chun, Felix K. H.
    Tilki, Derya
    Graefen, Markus
    Delouya, Guila
    Taussky, Daniel
    Wurnschimmel, Christoph
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (02) : 57.e15 - 57.e23
12345